What is the appropriate evaluation and management for silent sinus syndrome?

Silent Sinus Syndrome: Evaluation and Management

CT maxillofacial without contrast is the imaging modality of choice for diagnosing silent sinus syndrome, and functional endoscopic sinus surgery (FESS) alone is the definitive treatment that effectively resolves both sinonasal and ocular manifestations without routine need for orbital floor reconstruction. 1

Clinical Presentation and Diagnosis

Silent sinus syndrome presents as a diagnostic challenge because patients typically have prominent ocular symptoms without nasal complaints. The classic triad includes:

• Unilateral enophthalmos (2-5 mm retraction)
• Hypoglobus (downward displacement of the globe)
• Painless, slowly progressive course 2, 3, 4

Key Clinical Features to Recognize:

Ocular manifestations (present in 100% of cases):

• Globe asymmetry and facial asymmetry
• Binocular diplopia (occurs in subset of patients)
• Eyelid asymmetry or retraction
• Decreased vision in some cases 3, 5

Nasal symptoms are notably absent in 75% of patients 4, which is why the condition is termed "silent." This absence of sinonasal complaints frequently leads to delayed diagnosis, with patients presenting to ophthalmology, neurology, or maxillofacial surgery rather than ENT 5.

Historical clues: 87.5% of patients have a remote history of facial trauma or prior sinus surgery, often 10-20 years before presentation 4. However, most patients cannot recall the exact onset of their condition.

Diagnostic Imaging

CT maxillofacial without IV contrast is the gold standard imaging modality for confirming silent sinus syndrome 1. The pathognomonic radiologic findings include:

Essential CT Features:

• Maxillary sinus atelectasis with decreased sinus volume
• Inward bowing of all sinus walls (medial, lateral, superior, posterior)
• Orbital floor depression and retraction
• Obstruction of the ostiomeatal complex/infundibulum
• Lateralization of the uncinate process (present in 78% of cases)
• Osseous thinning and rarefaction of sinus walls
• Complete sinus opacification
• Increased orbital volume 1, 6, 4

CT is superior to MRI for evaluating silent sinus syndrome because it better delineates the critical osseous findings including bone thinning, ostial obstruction, and uncinate process lateralization 1. While MRI can demonstrate the decreased sinus volume and wall bowing, it lacks the bony detail necessary for surgical planning.

Common Pitfall:

Do not perform MRI as the initial imaging study—the lack of bony detail makes it inadequate for both diagnosis and surgical planning in this condition 1.

Treatment Algorithm

First-Line Definitive Treatment: FESS Alone

Functional endoscopic sinus surgery is the standard of care and should be performed as a single-stage procedure 1, 2. The surgical goals are:

1. Create wide middle meatal antrostomy to restore maxillary sinus ventilation
2. Address ostiomeatal complex obstruction
3. Correct anatomic variants (lateralized uncinate process, septal deviation if present)
4. Re-establish normal sinus aeration 2, 6, 4

Evidence for FESS-Only Approach:

The most recent high-quality evidence demonstrates that FESS alone provides excellent outcomes without routine orbital floor reconstruction:

• Zero recurrences after FESS alone in long-term follow-up (mean 4.71 years) 2
• Complete or near-complete resolution of both sinonasal and ocular symptoms in 100% of patients 2
• Normalization or improvement of enophthalmos/hypoglobus through spontaneous orbital self-reconstruction after sinus re-aeration 2, 4
• Mean quality of life score of 4.58/5 2
• Only 4.2% required orbital floor reconstruction in the largest recent series 2

When to Consider Two-Stage Approach:

Orbital floor reconstruction should be reserved for select cases only and is not performed routinely 2, 6. Consider a second-stage orbital procedure only if:

1. Persistent diplopia remains 3-6 months after FESS despite sinus re-aeration
2. Cosmetically unacceptable enophthalmos persists after adequate follow-up and patient remains dissatisfied
3. Patient specifically requests additional cosmetic correction after being informed of outcomes 3, 6

In one series, only 45% of patients (10/22) elected for second-stage orbital correction after FESS, with the remaining 55% satisfied with functional and cosmetic outcomes from sinus surgery alone 3.

Surgical Approach Options for Second Stage (if needed):

• Transconjunctival approach
• Endonasal endoscopic approach
• Nonsurgical intraorbital injections for minor residual enophthalmos 3, 6

Expected Outcomes and Follow-Up

Post-FESS outcomes are excellent and durable:

• Enophthalmos reduction from mean 3.5 mm to 0.5 mm
• Hypoglobus improvement from 2 mm to 0 mm
• Diplopia resolution in most cases
• No intraoperative complications or revision surgeries in recent series
• Mean follow-up extending beyond 4 years shows sustained benefit 2, 3

Critical Point on Timing:

Early diagnosis and treatment are essential. Delayed diagnosis (sometimes years after symptom onset) can lead to prolonged patient suffering and potentially more severe orbital deformity 7, 5. However, even long-standing cases respond well to FESS.

Multidisciplinary Considerations

Maintain high index of suspicion when patients present with:

• Spontaneous unilateral enophthalmos
• Facial asymmetry
• Infraorbital paresthesia
• Globe asymmetry
• Even in the absence of nasal symptoms or sinus pain 7, 5

Prompt ENT referral is warranted for any patient with unexplained unilateral enophthalmos, as this prevents diagnostic delay and allows for timely surgical intervention that can halt disease progression and restore normal anatomy 7.